Decrease in cellularity and expression of adhesion molecules by anti- tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 7, 1996, Pages 1077-1081

  Tak, Paul P ^a   Taylor, Peter C ^b   Breedveld, Ferdinand C ^a   Smeets, Tom J M ^a   Daha, Mohamed R ^a   Kluin, Philip M ^a   Meinders, A Edo ^a   Maini, Ravinder N ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG EFFECT; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; E-SELECTIN; HUMANS; LYMPHOCYTE ACTIVATION; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0029896957     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390702     Document Type: Article

References (17)

1. Brennan FM, Maini RN, Feldmann M: TNFα - a pivotal role in rheumatoid arthritis? Br J Rheumatol 31:293-298, 1992
2. Maini RN, Elliott M, Brennan FM, Williams R, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M: Monoclonal anti-TNF-alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 144:195-223, 1995
3. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeh J, Woody JN: Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 36:1681-1690, 1993
4. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Brecdveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
6. Paulus HE, Egger MJ, Ward JR, Williams JH, and the Cooperative Systematic Studies of Rheumatic Diseases Group: Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 33:477-484, 1990
7. Tak PP, van der Lubbe PA, Cauli A, Daha MR, Smeets TJM, Kluin PM, Meinders AE, Yanni G, Panayi GS, Breedveld FC: Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 38:1457-1465, 1995
8. Tak PP, Thurkow EW, Daha MR, Kluin PM, Smeets TJM, Meinders AE, Breedveld FC: Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol 77:236-242, 1995
9. Van der Lubbe PA, Dijkmans BAC, Markusse HM, Nässander U, Breedveld FC: A randomized double-blind placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis Rheum 38:1097-1106, 1995
10. Philip R, Epstein LB: Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323:86-89, 1986
11. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D: Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 163:1363-1375, 1986
12. Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billiau A, van Snick J: Identification of the human 26-kD protein, interferon beta2 (IFN beta2), as a B cell hybridoma/ plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 165:914-919, 1987
13. Brennan FM, Chantry D, Jackson A, Maini RN, Feldmann M: Inhibitory effect of TNF-alpha antibodies on synovial cell interleukin 1 production in rheumatoid arthritis. Lancet ii:244-247, 1989
14. Haworth C, Brennan FM, Chantry D, Maini RN, Feldmann M: Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha. Eur J Immunol 21:2575-2579, 1991
15. Chapman PT, Haskard DO: Leukocyte adhesion molecules. Br Med Bull 51:296-311, 1995
16. Paleolog EM, Hunt M, Elliott MJ, Feldmann M, Maini RN, Woody JN: Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor a antibody in rheumatoid arthritis. Arthritis Rheum 39:1082-1091, 1996
17. Issekutz AC, Meager A, Otterness I, Issekutz TB: The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leukocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin Exp Immunol 97:26-32, 1994